BDSI competitors

Zippia score 4.0

Competitor Summary. See how BDSI compares to its main competitors:

Salix Pharmaceuticals has the most employees (1,000).
The oldest company is Brad Pharm, founded in 1985.

Work at BDSI?

Share your experience

BDSI vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
BDSI	1997	4.0	Raleigh, NC	1	$166.7M	200
Indivior	1994	4.8	Richmond, VA	1	$265.8M	750
Zogenix	2006	4.4	Emeryville, CA	1	$81.7M	90
Salix Pharmaceuticals	1989	4.2	Raleigh, NC	2	$1.1B	1,000
Vicor Technologies	2000	3.7	Boca Raton, FL	1	$1.2M	10
Quinnova Pharmaceuticals Including Sarms, Peptides and More	2003	3.4	Newtown, PA	1	$5.3M	75
BDI Pharma	1995	3.2	Columbia, SC	1	$620,000	50
Insightra Medical	2001	4.2	Irvine, CA	2	$3.1M	31
Primus Pharmaceuticals	2000	3.9	Scottsdale, AZ	1	$17.5M	50
Aqua Pharmaceuticals	2004	4.3	West Chester, PA	1	$8.6M	71
Arbor Pharmaceuticals	2006	4.6	Atlanta, GA	1	$175.0M	157
Axcan Pharma US Inc	1991	4.2	Birmingham, AL	1	$470.4M	525
DUSA Pharmaceuticals	1991	4.4	Wilmington, MA	1	$45.3M	50
Brad Pharm	1985	4.3	Fairfield, NJ	1	$145.0M	300

Rate BDSI's competitiveness in the market.

BDSI salaries vs competitors

Compare BDSI salaries vs competitors

Company	Average salary	Hourly salary	Salary score
BDSI	$75,382	$36.24	-

Compare BDSI job title salaries vs competitors

Company	Highest salary	Hourly salary
BDSI	$71,395	$34.32
Salix Pharmaceuticals	$100,449	$48.29
Zogenix	$78,507	$37.74
Axcan Pharma US Inc	$76,793	$36.92
DUSA Pharmaceuticals	$75,706	$36.40
Aqua Pharmaceuticals	$73,824	$35.49
Arbor Pharmaceuticals	$73,142	$35.16
Quinnova Pharmaceuticals Including Sarms, Peptides and More	$72,503	$34.86
Primus Pharmaceuticals	$72,356	$34.79
Brad Pharm	$72,231	$34.73
Insightra Medical	$71,957	$34.59
BDI Pharma	$71,468	$34.36
Vicor Technologies	$71,283	$34.27
Indivior	$68,705	$33.03

Do you work at BDSI?

Is BDSI able to compete effectively with similar companies?

BDSI jobs

BDSI demographics vs competitors

Compare gender at BDSI vs competitors

Job title	Male	Female
Primus Pharmaceuticals	46%	54%
Zogenix	51%	49%
BDSI	52%	48%
Arbor Pharmaceuticals	55%	45%
BDI Pharma	63%	37%

Male

Female

100%

75%

50%

25%

BDI Pharma

Arbor Pharmaceuticals

BDSI

Zogenix

Primus Pharmaceuticals

25%

50%

75%

100%

Compare race at BDSI vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
BDSI	63%	19%	11%	4%	3%	7.0
Zogenix	60%	18%	9%	9%	4%	6.9
Arbor Pharmaceuticals	65%	10%	16%	5%	4%	7.8
Primus Pharmaceuticals	60%	21%	11%	5%	4%	6.6
BDI Pharma	59%	8%	21%	7%	4%	6.3

BDSI revenue vs competitors

BDSI revenue is $166.7M. Among it's competitors, the company with the highest revenue is Salix Pharmaceuticals, $1.1B . The company with the lowest revenue is BDI Pharma, $620.0K.

BDSI and similar companies CEOs

CEOBio

Stephen J. Farr

Zogenix

Stephen J. Farr, Ph.D. is one of our co-founders and has served as our President and as a member of our board of directors since August 2006. From 1995 to August 2006, Dr. Farr held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation, and he served most recently as Senior Vice President and Chief Scientific Officer. In 2003, he played a key role in identifying and acquiring the DosePro technology and became technical director and executive sponsor for the development of sumatriptan DosePro at Aradigm Corporation. From 1986 to 1994, Dr. Farr was a tenured professor at the Welsh School of Pharmacy, Cardiff University, United Kingdom, concentrating in the areas of physical pharmacy and biopharmaceutics. He is a fellow of the American Association of Pharmaceutical Scientists and visiting Associate Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University. Dr. Farr is a registered pharmacist in the United Kingdom and obtained his Ph.D. degree in Pharmaceutics from the University of Wales.

John Fraher

Axcan Pharma US Inc

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Laura Crossley

Indivior

Mark was appointed to his current position as Chief Strategy Officer in October 2014. He joined the Company in 2012 as the Global Finance Director with responsibilities for Finance, Information Systems and Procurement. Prior to joining Reckitt Benckiser Pharmaceuticals, Mark spent 13 years at Procter & Gamble in both corporate and current business roles including Associate Director Strategic and Business Planning, Finance Director Female Beauty, and Associate Director Corporate Portfolio Finance, as well as multiple roles in Corporate Treasury and its Baby Care division. He also enjoyed an eight year career with various operational and staff assignments in the United States Coast Guard.

Carolyn Logan

Salix Pharmaceuticals

Daniel Glassman

Brad Pharm

Patrizio Vinciarelli Ph.d

Vicor Technologies

James D. Weir

Primus Pharmaceuticals

J.D. Weir is a Chief Executive Officer at PRIMUS PHARMACEUTICALS INC and is based in United States.

Jeffrey S. Day

Quinnova Pharmaceuticals Including Sarms, Peptides and More